LAPIX Therapeutics

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://lapix.com/

Last Round

Series A

Aug 5, 2024

Total Funding Raised

$11.6M

Company Overview

LAPIX Therapeutics is a biopharmaceutical company that develops novel, orally bioavailable immune system restoration therapies for the treatment of autoimmune diseases and oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule drugsimmunomodulatorsdrug discoveryautoimmune diseaseimmune toleranceTIM pathwayclinical trialsoncology therapeuticsbiotech startupdrug pipelineinflammatory bowel diseaseIBDtherapeutic candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LAPIX Therapeutics Comparables

Compare LAPIX Therapeutics with similar companies based on industry and business-model similarity.

LAPIX Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Anokion	78%
Treg Therapeutics	78%
Merck & Co., Inc.	72%

View all Comparables

LAPIX Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Aug 5, 2024
Series A	Apr 27, 2023
Seed	Oct 18, 2022
Seed	Aug 23, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Anas Fathallah

Co-Founder And CEO

Founding Team

LAPIX Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

LAPIX Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LAPIX Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range12

Year Founded2019

Last FundingAug 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.